Mandate

Vinge advises Industrifonden in connection with investment in Footway

January 26, 2012

Vinge has advised Industrifonden in connection with its investment in Footway, an e-trading company which sells shoes online. The investment was part of a new issue of shares under which Footway raised SEK 28 million from Industrifonden, eEquity and the company’s founders.  One of the key figures in Footway is Daniel Mühlbach, who played a prominent role in the success of Lensway. The money will be used for Footway’s expansion in the Nordic region.

Industrifonden invests in small and medium sized companies which exhibit the potential for international growth. The fund has assets of SEK 3.8 billion and investments in 89 companies within the technology, cleantech, life science and industrial sectors. 

Vinge’s team consisted of partner Johan Larsson and associate Martin Hall.

Related

Vinge advises Fortinova Fastigheter AB (publ) on its first SEK 200 million green bond issue

Vinge has advised Fortinova Fastigheter AB (publ) (“Fortinova”) on the company’s first issue of senior unsecured green bonds in an aggregate principal amount of SEK 200 million, under a framework of up to SEK 600 million. Nordea, acted as sole bookrunner in connection with the bond issue.
September 18, 2026

Vinge advises Morrow Bank AB (publ) in connection with the bank’s sale of parts of MedMera Bank and the sale of NPL portfolios

Vinge has advised Morrow Bank AB (publ) in connection with the divestment of parts of MedMera Bank’s operations to a leading global credit investment firm. The divestment is structured as a sale of shares and priced at a premium of approximately SEK 90 million above equity value as per the completion date. The transaction includes parts of MedMera’s banking operations such as IT infrastructure, organisation and management, whilst Morrow Bank retains MedMera’s performing loans, deposits, customers, the MedMera brand, the Coop partnership agreement as well as key personnel.
September 15, 2026

Vinge advises HealthCap in conjunction with its investment in AMRA Medical

HealthCap is investing in AMRA Medical AB, a company that analyses whole-body MRI images to classify and quantify an individual’s muscle and fat tissue throughout the body and places this in relation to human health and disease.
September 15, 2026